Informations générales (source: ClinicalTrials.gov)
Evaluation of the Effectiveness of the TOVERTAFEL System on Behavioral Disorders of People With Cognitive Disorders Hospitalized in Long-Term Care Units and in Reinforced Hosting Unit (TOVERTAFEL)
Interventional
N/A
Hospices Civils de Lyon (Voir sur ClinicalTrials)
septembre 2020
août 2021
29 juin 2024
The prevalence of behavioral disorders is high in patients living in an institutional
environment or hospitalized in a long-term care unit. The consequences of these symptoms
are not negligible with a faster cognitive decline and a significant impact on the life
of the institution and of other patients when the disorders are pervasive and too
difficult to manage for the healthcare teams.
Despite the daily attention paid to these disorders and their causes, especially the
environmental ones, the teams are sometimes helpless, the teams are sometimes helpless
today to fight against these symptoms, and their management thus constitutes a real
challenge.
Non-drug interventions targeting this problem often require additional training,
architectural installations (Snoezelen space) and / or are moderately effective. In order
to offer a solution that can be used by everyone, that is transportable and based on new
technologies, the TOVERTAFEL device was created.
These are interactive games projected onto a table using a ceiling projector. The light
animations invite people to "play with the light" using arm or hand movements. These
games stimulate residents' physical activity and encourage interactions between residents
and with caregivers.
In this study, it is a question of evaluating the effectiveness of the TOVERTAFEL device
on the frequent behavioral symptoms in dementia (agitation, ambulation, apathy, anxiety),
the quality of life of the patients, as well as on psychotropic treatments.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Hôpital des Charpennes - 69100 - Villeurbanne - France | Floriane Delphin-Combe | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Man or woman aged 60 to 106.
- Patient living in one of the USLD or UHR participating in the project.
- Score greater than or equal to 9 for at least one of the following items in the
NPI-ES: apathy, agitation, anxiety, depression, aberrant motor behavior.
- Presence of TNC according to the standardization and calibration of the MMSE.
- The patients recruited must have given themselves, or through a trusted person
provided for in article L. 1111-6 of the Public Health Code, failing this, by the
family, or, failing that, by a person having close and stable ties with the person
concerned; for adults under guardianship: the guardian or legal representative, for
adults under guardianship: the curator, their informed consent to this study which
must be approved by the Personal Protection Committee (PPC) prior to its completion.
- Man or woman aged 60 to 106.
- Patient living in one of the USLD or UHR participating in the project.
- Score greater than or equal to 9 for at least one of the following items in the
NPI-ES: apathy, agitation, anxiety, depression, aberrant motor behavior.
- Presence of TNC according to the standardization and calibration of the MMSE.
- The patients recruited must have given themselves, or through a trusted person
provided for in article L. 1111-6 of the Public Health Code, failing this, by the
family, or, failing that, by a person having close and stable ties with the person
concerned; for adults under guardianship: the guardian or legal representative, for
adults under guardianship: the curator, their informed consent to this study which
must be approved by the Personal Protection Committee (PPC) prior to its completion.
- Unstable pathology whose nature can interfere with the evaluation variables
- Deafness or blindness which could compromise the patient's assessment or his
participation in the animation sessions.